The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’
Many cancer drugs remain unproven 5 years after accelerated approval: study courant.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from courant.com Daily Mail and Mail on Sunday newspapers.
New research questions the effectiveness of the FDA's accelerated drug approval program after finding that most cancer drugs remain unproven five years later.